Overview

Definition:
-An enterovesical fistula is an abnormal tract connecting the intestinal tract (enteron) to the urinary bladder (vesica)
-It results in the abnormal passage of intestinal contents (such as gas or feces) into the bladder, and urine into the intestinal tract
-This leads to significant morbidity, including recurrent urinary tract infections, pneumaturia, fecaluria, and sepsis
-The most common causes are iatrogenic, due to surgery or radiation, followed by inflammatory bowel disease and malignancy.
Epidemiology:
-Enterovesical fistulas are relatively rare, with an incidence that varies depending on the underlying etiology
-Post-surgical fistulas account for the majority, particularly after gynecological, colorectal, and urological procedures
-Diverticulitis is the most common non-iatrogenic cause, accounting for up to 30% of cases
-Malignancy-related fistulas are also significant, often associated with advanced pelvic cancers
-The incidence of radiation-induced fistulas has decreased with improved radiotherapy techniques.
Clinical Significance:
-Enterovesical fistulas represent a significant challenge in surgical practice due to their complex etiology and potential for severe complications
-Early diagnosis and appropriate management are crucial to prevent life-threatening sepsis, improve quality of life by alleviating distressing symptoms like pneumaturia and fecaluria, and optimize patient outcomes
-Understanding the different etiologies and surgical approaches is vital for residents preparing for DNB and NEET SS examinations.

Clinical Presentation

Symptoms:
-Recurrent urinary tract infections unresponsive to standard treatment
-Pneumaturia (passage of gas bubbles in urine) is a hallmark symptom
-Fecaluria (passage of fecal matter in urine) is pathognomonic but less common
-Suprapubic pain and discomfort
-Bladder irritation symptoms like urgency and frequency
-Fever and chills may indicate associated infection or sepsis
-Passage of purulent discharge from the urethra.
Signs:
-Tenderness in the suprapubic region or lower abdomen
-Palpable abdominal mass in cases of associated inflammatory process or malignancy
-Signs of systemic infection like fever, tachycardia, and hypotension in severe cases
-Digital rectal examination may reveal inflammation or a fistula tract in the perianal area
-In women, pelvic examination may reveal signs of inflammation or fistula.
Diagnostic Criteria:
-Diagnosis is primarily clinical, supported by investigations
-The presence of pneumaturia and/or fecaluria strongly suggests an enterovesical fistula
-Recurrent, severe UTIs in the absence of typical risk factors should raise suspicion
-While no formal diagnostic criteria exist, the combination of suggestive symptoms and positive imaging findings confirms the diagnosis.

Diagnostic Approach

History Taking:
-Detailed history of previous abdominal or pelvic surgery, particularly involving the bowel, bladder, or gynecological organs
-History of radiation therapy to the pelvis
-History of inflammatory bowel disease (Crohn's disease, ulcerative colitis)
-History of pelvic malignancy or its treatment
-Onset and progression of symptoms, especially pneumaturia, fecaluria, and recurrent UTIs
-Presence of any associated systemic symptoms like fever or weight loss.
Physical Examination:
-General examination focusing on signs of systemic illness (fever, dehydration, malnutrition)
-Abdominal examination for tenderness, masses, and signs of peritonitis
-Digital rectal examination to assess for rectal involvement, inflammation, or tenderness
-Pelvic examination in women to assess for gynecological causes or involvement
-Examination of the external genitalia for any discharge.
Investigations:
-Urinalysis and urine culture to identify infection and assess for fecal contamination
-Complete blood count (CBC) to assess for leukocytosis and anemia
-Imaging modalities: Cystography with contrast is highly sensitive for detecting fistulas, often showing contrast filling the bowel
-CT scan of the abdomen and pelvis with oral and IV contrast is crucial for delineating the fistula tract, identifying the involved bowel segment, and assessing associated inflammatory changes or complications
-MRI may be useful in specific cases, particularly for evaluating pelvic anatomy and soft tissues
-Colonoscopy or sigmoidoscopy may be indicated to assess for inflammatory bowel disease or colonic pathology
-Cystoscopy is essential to visualize the bladder opening of the fistula and assess the bladder mucosa for inflammation or tumor involvement.
Differential Diagnosis:
-Severe urinary tract infections with gas-forming organisms (e.g., Klebsiella)
-Bladder diverticula
-Pelvic abscesses with bladder erosion
-Malignancy of the bladder or adjacent organs invading the bladder
-Intra-abdominal abscesses with bladder fistulization
-Severe inflammatory conditions of the pelvis not involving the bowel or bladder directly.

Management

Initial Management:
-Antibiotic therapy to treat or prevent sepsis and recurrent UTIs
-Aggressive fluid resuscitation and nutritional support
-Management of underlying causes, such as bowel obstruction or perforation, if present
-Stoma formation (colostomy or ileostomy) may be necessary for fecal diversion in severe cases or as a temporizing measure.
Medical Management:
-Prophylactic antibiotics to prevent recurrent UTIs
-Antiemetics and analgesics for symptomatic relief
-Nutritional optimization through oral or parenteral routes
-Management of inflammatory bowel disease with appropriate medical therapy if it is the underlying cause.
Surgical Management:
-Surgical intervention is typically required for definitive treatment
-The goals of surgery are to resect the diseased bowel segment, close the fistula, and reconstruct the involved organs
-Key surgical steps include: 1
-Bowel resection: Excision of the involved segment of the intestine (e.g., colon, small bowel)
-2
-Fistula closure: Direct closure of the fistula orifice in the bladder and bowel, or creation of a new ostomy
-3
-Reconstruction: Reconstruction of the gastrointestinal tract (e.g., anastomosis) and urinary tract if necessary
-Urinary diversion (e.g., ileal conduit, suprapubic cystostomy) may be required in complex cases or if bladder reconstruction is not feasible
-Conservative management with only stoma diversion may be considered in critically ill patients or those with extensive comorbidities, with definitive repair deferred.
Supportive Care:
-Close monitoring of vital signs and fluid balance
-Aggressive pain management
-Strict adherence to antibiotic regimens
-Nutritional support, including high-protein, low-residue diet, and parenteral nutrition if indicated
-Psychological support for patients experiencing debilitating symptoms and facing major surgery.

Complications

Early Complications:
-Sepsis and septic shock from contaminated urine and bowel contents
-Anemia due to chronic blood loss or poor nutrition
-Wound infection and dehiscence
-Anastomotic leak if bowel resection and reanastomosis are performed
-Formation of pelvic abscess.
Late Complications:
-Recurrent fistulas
-Adhesions and bowel obstruction
-Strictures at the site of anastomosis or in the urinary tract
-Impotence or sexual dysfunction
-Psychological distress
-Incisional hernias.
Prevention Strategies:
-Meticulous surgical technique during pelvic procedures to avoid inadvertent bowel or bladder injury
-Careful dissection and identification of anatomy
-Prompt recognition and repair of intraoperative injuries
-Judicious use of radiation therapy
-Early diagnosis and management of inflammatory bowel disease
-Careful postoperative monitoring for early signs of complications.

Prognosis

Factors Affecting Prognosis:
-The underlying etiology is a major prognostic factor, with iatrogenic fistulas generally having a better prognosis than those due to malignancy or extensive inflammatory disease
-The patient's overall health status, presence of comorbidities, and the extent of disease significantly impact outcomes
-Timeliness of diagnosis and treatment also plays a critical role.
Outcomes:
-With timely and appropriate surgical intervention, the prognosis for enterovesical fistula repair is generally favorable, with high success rates
-Symptom resolution (cessation of pneumaturia and fecaluria) is typically achieved
-Long-term complications can occur and require ongoing management
-Morbidity and mortality rates are higher in patients with severe sepsis, advanced malignancy, or significant comorbidities.
Follow Up:
-Regular follow-up is essential to monitor for recurrence, assess for long-term complications such as bowel obstruction or strictures, and manage any residual issues
-Follow-up may include clinical assessment, urinalysis, and imaging studies depending on the original etiology and surgical procedure performed
-Patients with inflammatory bowel disease require ongoing gastroenterological care.

Key Points

Exam Focus:
-Pneumaturia and fecaluria are pathognomonic symptoms
-CT scan is the investigation of choice for delineating the fistula
-Surgical resection of involved bowel and closure of the fistula is the definitive management
-Consider urinary diversion in complex cases.
Clinical Pearls:
-Always consider an enterovesical fistula in patients with recurrent, unexplained UTIs, especially if they have a history of pelvic surgery or radiation
-Be vigilant for subtle signs of fecal contamination in urine
-Multidisciplinary approach involving urology, general surgery, gastroenterology, and radiology is often necessary.
Common Mistakes:
-Delaying surgical intervention in favor of conservative management when definitive repair is indicated
-Inadequate bowel resection leading to recurrence
-Failure to adequately assess and manage associated complications like sepsis or abscess
-Misinterpreting imaging findings or missing concomitant pathology.